These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
78 related items for PubMed ID: 1543526
21. Synthesis, antibacterial, antifungal activity and interaction of CT-DNA with a new benzimidazole derived Cu(II) complex. Arjmand F, Mohani B, Ahmad S. Eur J Med Chem; 2005 Nov; 40(11):1103-10. PubMed ID: 16006016 [Abstract] [Full Text] [Related]
22. Synthesis, characterization, and in vitro evaluation of a potentially selective anticancer, mixed-metal [ruthenium(III)-platinum(II)] trinuclear complex. Herman A, Tanski JM, Tibbetts MF, Anderson CM. Inorg Chem; 2008 Jan 07; 47(1):274-80. PubMed ID: 18062685 [Abstract] [Full Text] [Related]
30. Selective cytotoxic Ru(II) arene Cp* complex salts [R-PhRuCp*](+)X(-) for X = BF4(-), PF6(-), and BPh4(-). Loughrey BT, Healy PC, Parsons PG, Williams ML. Inorg Chem; 2008 Oct 06; 47(19):8589-91. PubMed ID: 18783214 [Abstract] [Full Text] [Related]
31. DNA binding and photocleavage in vitro by new dirhodium(II) dppz complexes: correlation to cytotoxicity and photocytotoxicity. Angeles-Boza AM, Bradley PM, Fu PK, Wicke SE, Bacsa J, Dunbar KR, Turro C. Inorg Chem; 2004 Dec 27; 43(26):8510-9. PubMed ID: 15606200 [Abstract] [Full Text] [Related]
36. Mechanistic Studies of Ruthenium-Catalyzed Anti-Markovnikov Hydroamination of Vinylarenes: Intermediates and Evidence for Catalysis through pi-Arene Complexes. Takaya J, Hartwig JF. J Am Chem Soc; 2005 Apr 27; 127(16):5756-7. PubMed ID: 15839651 [Abstract] [Full Text] [Related]
37. Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity. Peacock AF, Parsons S, Sadler PJ. J Am Chem Soc; 2007 Mar 21; 129(11):3348-57. PubMed ID: 17319668 [Abstract] [Full Text] [Related]
39. Antitumor agents 4. Characterization of free radicals produced during reduction of the antitumor drug 5H-pyridophenoxazin-5-one: an EPR study. Alberti A, Bolognese A, Guerra M, Lavecchia A, Macciantelli D, Marcaccio M, Novellino E, Paolucci F. Biochemistry; 2003 Oct 21; 42(41):11924-31. PubMed ID: 14556623 [Abstract] [Full Text] [Related]